Health-care companies rose after a round of generally strong earnings.
Pfizer shares rose after the drug giant said strong cancer-drug sales offset weakness elsewhere.
BioNTech plans to shrink its workforce and manufacturing network, as the German biotech company seeks to regain its footing following a drop in demand for Covid-19 vaccines.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
05-05-26 1717ET



















